Posted in | News | Plastics and Polymers

INEOS Technologies Signs Agreement with Russia Leading Petrochemical Company

Sibur LLC has selected INEOS' Innovene PP Process for a new 200,000 tpa polypropylene plant to be constructed at the production site of Tomskneftekhim LLC, Tomsk, Russian Federation.

The Tomsk plant will be the nineteenth to use the Innovene PP process. It will produce a full range of homopolymer, random and impact copolymers and is expected to commence production in 2012.

The Innovene PP process is licensed by INEOS Technologies, which is the specialist technologies development and licensing division of INEOS Group.

Sibur previously licensed a 500,000 tpa plant based on Innovene PP technology at its industrial complex in Tobolsk, Tyumen Region, Russian Federation.

“We are very pleased that we have extended our licensing partnership with Sibur,” said Mark Niederschulte, Vice President - Commercial of INEOS Technologies. “The Innovene PP Process has proven to be the preferred technology for new PP plants due to its low operating and capital costs, broad product capability and operational reliability. In addition to its demonstrated commercial success, the Innovene PP process affords significant advantages for future expansions.”

INEOS Technologies provides Sibur with a complete and flexible technology that will help it to secure a long-term competitive position.

Posted March 30th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.